ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,030 | -70.1% | 85 | -61.4% | 0.00% | -100.0% |
| Q2 2023 | $10,149 | +31.8% | 220 | +14.6% | 0.00% | 0.0% |
| Q1 2023 | $7,699 | -62.2% | 192 | -56.4% | 0.00% | -66.7% |
| Q4 2022 | $20,385 | +307.7% | 440 | +286.0% | 0.00% | +200.0% |
| Q3 2022 | $5,000 | +150.0% | 114 | +307.1% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 28 | +16.7% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 24 | +242.9% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 7 | -58.8% | 0.00% | – |
| Q4 2019 | $1,000 | -75.0% | 17 | -80.5% | 0.00% | -100.0% |
| Q3 2019 | $4,000 | 0.0% | 87 | +38.1% | 0.00% | 0.0% |
| Q2 2019 | $4,000 | 0.0% | 63 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +100.0% | 63 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $2,000 | – | 63 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |